{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:01:26Z","timestamp":1790676086612,"version":"4.1.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018234","name":"Inselspital, Universit\u00e4tsspital Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"Universit\u00e4t Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:p>\n                    Almost half of inpatients on parenteral nutrition experience hyperglycemia, which increases the risk of complications and mortality. The blood glucose target for hospitalized patients on parenteral nutrition is 7.8 to 10.0 mmol\/L (140 to 180 mg\/dL). For patients with diabetes, the same parenteral nutrition formulae as for patients without diabetes can be used, as long as blood glucose levels can be adequately controlled using insulin. Insulin can be delivered\n                    <jats:italic>via<\/jats:italic>\n                    the subcutaneous or intravenous route or, alternatively, added to parenteral nutrition admixtures. Combining parenteral with enteral and oral nutrition can improve glycemic control in patients with sufficient endogenous insulin stores. Intravenous insulin infusion is the preferred route of insulin delivery in critical care as doses can be rapidly adjusted to altered requirements. For stable patients, insulin can be added directly to the parenteral nutrition bag. If parenteral nutrition is infused continuously over 24 hours, the subcutaneous injection of a long-acting insulin combined with correctional bolus insulin may be adequate. The aim of this review is to give an overview of the management of parenteral nutrition-associated hyperglycemia in inpatients with diabetes.\n                  <\/jats:p>","DOI":"10.3389\/fcdhc.2022.829412","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T06:01:28Z","timestamp":1645423288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Management of Hyperglycemia in Hospitalized Patients Receiving Parenteral Nutrition"],"prefix":"10.3389","volume":"3","author":[{"given":"Katja A.","family":"Sch\u00f6nenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Reber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"D\u00fcrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annic","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Efthymiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina V.","family":"Huwiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Laimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Bally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Stanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607114521833","article-title":"A.S.P.E.N. Clinical Guidelines: Parenteral Nutrition Ordering, Order Review, Compounding, Labeling, and Dispensing","volume":"38","author":"Boullata","year":"2014","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN Guidelines on Chronic Intestinal Failure in Adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"key":"B3","unstructured":"National Diabetes Inpatient Audit (NaDIA) - 2018 United Kingdom2019"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12932","article-title":"Prevalence of Diabetes and Its Effects on Stroke Outcomes: A Meta-Analysis and Literature Review","volume":"10","author":"Lau","year":"2019","journal-title":"J\u00a0Diabetes Investig"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5694\/mja13.00104","article-title":"The High Burden of Inpatient Diabetes Mellitus: The Melbourne Public Hospitals Diabetes Inpatient Audit","volume":"201","author":"Bach","year":"2014","journal-title":"Med J Aust"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14124","article-title":"High Diabetes Prevalence and Insulin Medication Errors in Hospital Patients","volume":"48","author":"Taylor","year":"2018","journal-title":"Intern Med J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2013.45","article-title":"Malnutrition Risk in Newly Hospitalized Overweight and Obese Individuals: Mr NOI","volume":"67","author":"Leibovitz","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.03.012","article-title":"EuroOOPS: An International, Multicentre Study to Implement Nutritional Risk Screening and Evaluate Clinical Outcome","volume":"27","author":"Sorensen","year":"2008","journal-title":"Clin Nutr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000444096","article-title":"Unraveling the Link Between Malnutrition and Adverse Clinical Outcomes: Association of Acute and Chronic Malnutrition Measures With Blood Biomarkers From Different Pathophysiological States","volume":"68","author":"Felder","year":"2016","journal-title":"Ann Nutr Metab"},{"key":"B10","article-title":"Complications Associated With Central Venous Catheter Insertion and Care","volume-title":"Basics in Clinical Nutrition","author":"Sobocki","year":"2019"},{"key":"B11","article-title":"Metabolic Complications of Parenteral Nutrition","volume-title":"Basics in Clinical Nutrition","author":"Sobotka","year":"2019"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0884533609339069","article-title":"Hyperglycemic Events in Non-Intensive Care Unit Patients Receiving Parenteral Nutrition","volume":"24","author":"Pleva","year":"2009","journal-title":"Nutr Clin Pract"},{"key":"B13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4158\/EP13441.OR","article-title":"Prevalence of Diabetes, Prediabetes, and Stress Hyperglycemia: Insulin Therapy and Metabolic Control in Patients on Total Parenteral Nutrition (Prospective Multicenter Study)","volume":"21","author":"Olveira","year":"2015","journal-title":"Endocr Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2020.11.023","article-title":"Parenteral Nutrition-Associated Hyperglycemia: Prevalence, Predictors and Management","volume":"41","author":"Roszali","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.10.2367","article-title":"Hyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral Nutrition","volume":"28","author":"Cheung","year":"2005","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802178","article-title":"The Prediction of Resting Energy Expenditure in Type 2 Diabetes Mellitus is Improved by Factoring for Glycemia","volume":"26","author":"Gougeon","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13191","article-title":"Elevation of the Renal Threshold for Glucose Is Associated With Insulin Resistance and Higher Glycated Hemoglobin Levels","volume":"11","author":"Hieshima","year":"2020","journal-title":"J Diabetes Investig"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/0115426504019002120","article-title":"Management of Parenteral Nutrition in Acutely Ill Patients With Hyperglycemia","volume":"19","author":"McMahon","year":"2004","journal-title":"Nutr Clin Pract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive Insulin Therapy in the Medical ICU","volume":"354","author":"Van den Berghe","year":"2006","journal-title":"New Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S015","article-title":"15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.clnu.2009.04.024","article-title":"ESPEN Guidelines on Parenteral Nutrition: Intensive Care","volume":"28","author":"Singer","year":"2009","journal-title":"Clin Nutr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/0148607112452001","article-title":"A.S.P.E.N. Clinical Guidelines: Nutrition Support of Adult Patients With Hyperglycemia","volume":"37","author":"McMahon","year":"2013","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11892-017-0882-3","article-title":"Nutrition and Hyperglycemia Management in the Inpatient Setting (Meals on Demand, Parenteral, or Enteral Nutrition)","volume":"17","author":"Drincic","year":"2017","journal-title":"Curr Diabetes Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.metabol.2013.09.010","article-title":"Anti-Diabetic Actions of Glucagon-Like Peptide-1 on Pancreatic Beta-Cells","volume":"63","author":"Lee","year":"2014","journal-title":"Metabolism"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114509993631","article-title":"Combining Enteral With Parenteral Nutrition to Improve Postoperative Glucose Control","volume":"103","author":"Lidder","year":"2010","journal-title":"Br J Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/jcm8070935","article-title":"Management of Glucose Control in Noncritically Ill, Hospitalized Patients Receiving Parenteral and\/or Enteral Nutrition: A Systematic Review","volume":"8","author":"Laesser","year":"2019","journal-title":"J Clin Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.4.12.370","article-title":"A Biometric Study of Human Basal Metabolism","volume":"4","author":"Harris","year":"1918","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2017.06.025","article-title":"ESPEN Guidelines on Nutritional Support for Polymorbid Internal Medicine Patients","volume":"37","author":"Gomes","year":"2018","journal-title":"Clin Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/0148607115621863","article-title":"Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)","volume":"40","author":"McClave","year":"2016","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B31","volume-title":"Nutrition Support for Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition","year":"2017"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-012-0335-y","article-title":"Management of Hyperglycemia During Enteral and Parenteral Nutrition Therapy","volume":"13","author":"Gosmanov","year":"2013","journal-title":"Curr Diabetes Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4162\/nrp.2011.5.5.450","article-title":"Higher Dextrose Delivery via TPN Related to the Development of Hyperglycemia in Non-Diabetic Critically Ill Patients","volume":"5","author":"Lee","year":"2011","journal-title":"Nutr Res Pract"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199805000-00018","article-title":"Effects of Isoenergetic Glucose-Based or Lipid-Based Parenteral Nutrition on Glucose Metabolism, De Novo Lipogenesis, and Respiratory Gas Exchanges in Critically Ill Patients","volume":"26","author":"Tappy","year":"1998","journal-title":"Crit Care Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-2727-9","article-title":"Olive Oil Based Nutrition in Multiple Trauma Patients: A Pilot Study","volume":"31","author":"Huschak","year":"2005","journal-title":"Intensive Care Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1399-6576.1985.tb02336.x","article-title":"An Evaluation of Biochemical Aspects of Intravenous Fructose, Sorbitol and Xylitol Administration in Man","volume":"82","author":"Sestoft","year":"1985","journal-title":"Acta Anaesthesiol Scand Suppl"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601274","article-title":"Evaluation of Nonglucose Carbohydrates in Parenteral Nutrition for Diabetic Patients","volume":"55","author":"Valero","year":"2001","journal-title":"Eur J Clin Nutr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clnesp.2016.09.007","article-title":"Glutamine Dipeptide-Supplemented Parenteral Nutrition Improves the Clinical Outcomes of Critically Ill Patients: A Systematic Evaluation of Randomised Controlled Trials","volume":"17","author":"Stehle","year":"2017","journal-title":"Clin Nutr ESPEN"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/0148607110362587","article-title":"The Impact of Glutamine Dipeptide-Supplemented Parenteral Nutrition on Outcomes of Surgical Patients: A Meta-Analysis of Randomized Clinical Trials","volume":"34","author":"Wang","year":"2010","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/000313481307900527","article-title":"The Impact of Perioperative Glutamine-Supplemented Parenteral Nutrition on Outcomes of Patients Undergoing Abdominal Surgery: A Meta-Analysis of Randomized Clinical Trials","volume":"79","author":"Yue","year":"2013","journal-title":"Am Surg"},{"key":"B41","first-page":"7","article-title":"Metabolic Effects of Glutamine on Insulin Sensitivity","volume":"28","author":"Molfino","year":"2010","journal-title":"Nutr Ther Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/01.CCM.0000201004.30750.D1","article-title":"L-Alanyl-L-Glutamine Dipeptide-Supplemented Total Parenteral Nutrition Reduces Infectious Complications and Glucose Intolerance in Critically Ill Patients: The French Controlled, Randomized, Double-Blind, Multicenter Study","volume":"34","author":"Dechelotte","year":"2006","journal-title":"Crit Care Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2014.05.006","article-title":"The Influence of Parenteral Glutamine Supplementation on Glucose Homeostasis in Critically Ill Polytrauma Patients\u2013A Randomized-Controlled Clinical Study","volume":"34","author":"Grintescu","year":"2015","journal-title":"Clin Nutr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31820eb774","article-title":"The Effect\u00a0of L-Alanyl-L-Glutamine Dipeptide Supplemented Total Parenteral Nutrition on Infectious Morbidity and Insulin Sensitivity in Critically Ill Patients","volume":"39","author":"Grau","year":"2011","journal-title":"Crit Care Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/nu12061566","article-title":"Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients With TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study","volume":"12","author":"Abuin-Fernandez","year":"2020","journal-title":"Nutrients"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclnm.2009.06.020","article-title":"Basics in Clinical Nutrition: Nutritional Support in the Diabetic Patient","volume":"4","author":"Dardai","year":"2009","journal-title":"e-SPEN Eur. e-Journal Clin. Nutr Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/s0749-0704(05)70154-8","article-title":"Stress-Induced Hyperglycemia","volume":"17","author":"McCowen","year":"2001","journal-title":"Crit Care Clin"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000045568.12881.10","article-title":"Outcome Benefit of Intensive Insulin Therapy in the Critically Ill: Insulin Dose Versus Glycemic Control","volume":"31","author":"Van den Berghe","year":"2003","journal-title":"Crit Care Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1177\/0148607181005005436","article-title":"An Improved Method for Blood Glucose Control During Nutritional Support","volume":"5","author":"Woolfson","year":"1981","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2103068","article-title":"Practical Management of Diabetes in Critically Ill Patients","volume":"164","author":"Boord","year":"2001","journal-title":"Am. J Respir Crit Care Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1177\/0148607116644710","article-title":"Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study","volume":"41","author":"Hakeam","year":"2017","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1177\/0148607104028006s39","article-title":"Safe Practices for Parenteral Nutrition","volume":"28","author":"Mirtallo","year":"2004","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp060094","article-title":"Clinical Practice. Management of Hyperglycemia in the Hospital\u00a0Setting","volume":"355","author":"Inzucchi","year":"2006","journal-title":"New Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4158\/EP.12.6.641","article-title":"Conversion of Intravenous Insulin Infusions to Subcutaneously Administered Insulin Glargine in Patients With Hyperglycemia","volume":"12","author":"Schmeltz","year":"2006","journal-title":"Endocr Pract"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2019.02.036","article-title":"Regular Insulin Added to Total Parenteral Nutrition vs Subcutaneous Glargine in Non-Critically Ill Diabetic Inpatients, a Multicenter Randomized Clinical Trial: INSUPAR Trial","volume":"39","author":"Olveira","year":"2020","journal-title":"Clin Nutr"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-005-0200-4","article-title":"Use of Insulin Glargine in Patients With Hyperglycaemia Receiving Artificial Nutrition","volume":"42","author":"Fatati","year":"2005","journal-title":"Acta Diabetol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0035","article-title":"Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes","volume":"19","author":"Rodbard","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"B58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12916-017-0794-8","article-title":"Closed-Loop for Type 1 Diabetes - an Introduction and Appraisal for the Generalist","volume":"15","author":"Bally","year":"2017","journal-title":"BMC Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30061-0","article-title":"Fully Closed-Loop Insulin Delivery in Inpatients Receiving Nutritional Support: A Two-Centre, Open-Label, Randomised Controlled Trial","volume":"7","author":"Boughton","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1038\/s41598-018-24275-5","article-title":"Management of Glycemic Variation in Diabetic Patients Receiving Parenteral Nutrition by Continuous Subcutaneous Insulin Infusion (CSII) Therapy","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3390\/jcm8112017","article-title":"Pharmaceutical Aspects of Artificial Nutrition","volume":"8","author":"Reber","year":"2019","journal-title":"J Clin Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/0148607113511992","article-title":"A.S.P.E.N. Parenteral Nutrition Safety Consensus Recommendations","volume":"38","author":"Ayers","year":"2014","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2020.03.005","article-title":"ESPEN Guideline on Home Parenteral Nutrition","volume":"39","author":"Pironi","year":"2020","journal-title":"Clin Nutr"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/jpen.1024","article-title":"Insulin Instability in Parenteral Nutrition Admixtures","volume":"42","author":"Forchielli","year":"2018","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1177\/0115426590005003111","article-title":"Insulin Adsorption to Parenteral Infusion Systems: Case Report and Review of the Literature","volume":"5","author":"Seres","year":"1990","journal-title":"Nutr Clin Pract"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1177\/0148607117722750","article-title":"Addition of Insulin to Parenteral Nutrition for Control of Hyperglycemia","volume":"42","author":"McCulloch","year":"2018","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B67","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/pharmaceutics13040458","article-title":"Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study","volume":"13","author":"Henry","year":"2021","journal-title":"Pharmaceutics"},{"key":"B68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/014860710603000106","article-title":"Determinants of Insulin Availability in Parenteral Nutrition Solutions","volume":"30","author":"Christianson","year":"2006","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1177\/0148607190014003262","article-title":"Availability of Insulin From Total Parenteral Nutrition Solutions","volume":"14","author":"Marcuard","year":"1990","journal-title":"JPEN J Parenteral Enteral Nutr"},{"key":"B70","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/ajhp\/41.5.893","article-title":"Compatibility Considerations in Parenteral Nutrient Solutions","volume":"41","author":"Niemiec","year":"1984","journal-title":"Am J Hosp Pharm"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2015.08.003","article-title":"Quantitative Analysis of Insulin in Total Parenteral Nutrition Bag in Taiwan","volume":"24","author":"Yu","year":"2016","journal-title":"J Food Drug Anal"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819876924","article-title":"Capacity of Infusion Lines for Insulin Adsorption: Effect of Flow Rate on Total Adsorption","volume":"15","author":"Knopp","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-017-0311-0","article-title":"Immunoassay Quantification of Human Insulin Added to Ternary Parenteral Nutrition Containers: Comparison of Two Methods","volume":"409","author":"Henry","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1159\/000481355","article-title":"Insulin Regimens to Treat Hyperglycemia in Hospitalized Patients on Nutritional Support: Systematic Review and Meta-Analyses","volume":"71","author":"Vercoza Viana","year":"2017","journal-title":"Ann Nutr Metab"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2022.829412\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T06:01:39Z","timestamp":1645423299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2022.829412\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":74,"alternative-id":["10.3389\/fcdhc.2022.829412"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2022.829412","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"article-number":"829412"}}